Bernard Coulie, President and CEO of Pliant Therapeutics, Inc. (NASDAQ:PLRX), has sold a significant portion of his holdings in the company. According to a recent SEC filing, Coulie sold 52,419 shares ...

Stifel Financial Corp. (NYSE: SF) will release its fourth quarter and full year 2024 financial results before the market opens on Wednesday, January 29, 2025. The company will host a conference call ...

Stifel CEO Ron Kruszewski discusses deregulation, economic growth, his expectations for the Federal Reserve handling of rates ...

Stifel lowered the firm’s price target on FTAI Aviation (FTAI) to $100 from $167 and keeps a Buy rating on the shares after the company ...

Stifel initiated coverage of Structure Therapeutics (GPCR) with a Buy rating and $50 price target Structure aims to expand the reach of metabolic treatments across the large, heterogeneous obesity ...

Dave Kimball had served as CEO since June 2021, and the transition marks a new chapter for the beauty retailer. The leadership change and the positive financial outlook together have led Stifel to ...

Dave Kimball had served as CEO since June 2021, and the transition marks a new chapter for the beauty retailer. The leadership change and the positive financial outlook together have led Stifel to ...

On Monday, Stifel analysts maintained their Hold rating on Inseego Corp. (NASDAQ:INSG) with a steady price target of $12.00, following the announcement of a new CEO, Juho Sarvikas. The stock, which ...